Long-term improvement in renal function after cyclosporine reduction in renal transplant recipients with histologically proven chronic cyclosporine nephropathy

Transplantation

Volumn 65, Issue 5, 1998, Pages 661-667

  Mourad, Georges ^a   Vela, Carlos ^a   Ribstein, Jean ^a   Mimran, Albert ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALDOSTERONE; AZATHIOPRINE; BETA 2 MICROGLOBULIN; CREATININE; CYCLOSPORIN; IODOHIPPURATE SODIUM I 131; LYMPHOCYTE ANTIBODY; PENTETATE TECHNETIUM TC 99M; PREDNISOLONE; RENIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; KIDNEY TRANSPLANTATION; MALE; MEAN ARTERIAL PRESSURE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; TREATMENT OUTCOME;

ADULT; AGED; BIOPSY; BLOOD PRESSURE; CHRONIC DISEASE; CREATININE; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; TIME FACTORS;

EID: 0032521308     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199803150-00010     Document Type: Article

References (37)

1. Thorogood J, van Houwelingen JC, van Rood JJ, Zantvoort FA, Scheuder GMT, Persijn GG. Factors contributing to long-term kidney graft survival in Eurotransplant. Transplantation 1992; 54: 152.
2. Opelz G. Collaborative Transplant Study : 10-year report. Transplant Proc 1992; 24: 2342.
3. The Canadian Multicentre Transplant Study Group. A randomized clinical trial of cyclosporine in cadaveric renal transplantation: analysis at three years. N Engl J Med 1986; 314: 1219.
4. Calne RY. Cyclosporin in cadaveric renal transplantation: 5-year follow-up of a multicentre trial. Lancet 1987; 2: 506.
5. Fellström B. Immune injury: is it all there is to chronic graft rejection? Nephrol Dial Transplant 1995; 10: 149.
6. Paul LC, Fellström B. Chronic vascular rejection of the heart and kidney: have rational treatment options emerged? Transplantation 1992; 53: 1169.
7. Bennett WM, DeMattos A, Meyer MM, Andoh T, Barry JP. Chronic cyclosporine nephropathy: the Achille's heel of immunosuppressive therapy. Kidney Int 1996; 50: 1089.
8. Myers BD, Newton L, Oyer P. The case against the indefinite use of cyclosporine. Transplant Proc 1991; 23: 41.
9. Mihatsch MJ, Thiel G, Ryffel B. Histopathology of cyclosporine nephrotoxicity. Transplant Proc 1988; 20 (suppl 3): 759.
10. Versluis DJ, Wenting GJ, Derks FHM, Schalekamp MADH, Jeekel J, Weimar W. Who should be converted from cyclosporine to conventional immunosuppression in kidney transplantation and why? Transplantation 1987; 44: 387.
11. Versluis DJ, Kate FJWT, Wenting GJ, Jeekel J, Weimar W. Histological lesions associated with cyclosporin: incidence and reversibility in 1-yr-old kidney transplants. J Clin Pathol 1988; 41: 498.
12. Morozumi K, Thiel G, Albert FW, Banfi G, Gudat F, Mihatsch MJ. Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in renal allografts. Clin Nephrol 1992; 38: 1.
13. Mourad G, Vela C, Ribstein J, Mimran A. Chronic cyclosporine nephrotoxicity is reversible in renal transplant recipients [Abstract]. Nephrol Dial Transplant 1993; 8: 1045.
14. Mihatsch MJ, Ryffel B, Gudat F. The differential diagnosis between rejection and cyclosporine toxicity. Kidney Int 1995; 48 (suppl 52): 575.
15. Mimran A, Deschodt G. The role of the renin-angiotensin system in the hormonal and renal response to tilt in normal man. Renal Physiol 1983; 6: 36.
16. Cook DJ. Long-term survival of kidney allografts. In: Terasaki PI, ed. Clinical transplants 1987. Los Angeles: UCLA Tissue Typing Laboratory, 1987: 277.
17. Paul LC. Chronic renal transplant loss. Kidney Int 1995; 47: 1491.
18. Terasaki PI, Mickey MR, Cecka JM. Overview. In: Terasaki PI, ed. Clinical transplants 1987. Los Angeles: UCLA Tissue Typing Laboratory, 1987: 467.
19. Kahan BD, Welsh M, Schoenberg L, et al.Variable oral absorption of cyclosporine: a biopharmacological risk factor for chronic renal allograft rejection. Transplantation 1996; 62: 599.
20. Goldstein DJ, Zuech N, Sehgal V, Weinberg AD, Drusin R, Cohen D. Cyclosporine-associated end-stage nephropathy after cardiac transplantation. Transplantation 1997; 63: 664.
21. Myers BD, Ross J, Newton L, Luetscher J, Perlroth M. Cyclosporine-associated chronic nephropathy. N Engl J Med 1984; 311: 699.
22. McDiarmid SV, Ettenger RB, Fine RN, Busuttil RW, Ament ME. Serial decrease in glomerular filtration rate in long-term pediatric liver transplantation survivors treated with cyclosporine. Transplantation 1989; 47: 314.
23. Rodier M, Ribstein J, Parer-Richard C, Mimran A. Renal changes associated with cyclosporine in recent type I diabetes mellitus. Hypertension 1991; 18: 334.
24. Curtis JJ, Luke RG, Dubovsky E, Diethelm AG, Whelchel JD, Jones P. Cyclosporin in therapeutic doses increases renal allograft vascular resistance. Lancet 1986; 2: 477.
25. Klintmalm G, Sundelin B, Bohman S OL, Wilczek H. Interstitial fibrosis in renal allografts after 12 to 46 months of cyclosporin treatment: beneficial effect of low doses in early post-transplantation period. Lancet 1984; 2: 950.
26. Sommer BG, Innes JT, Whitehurst RM, Sharma HM, Ferguson RM. Cyclosporine-associated renal arteriopathy resulting in loss of allograft function. Am J Surg 1985; 149: 756.
27. Ruiz P, Kolbeck PC, Scroggs MW, Sanfilippo F. Associations between cyclosporine therapy and interstitial fibrosis in renal allograft biopsies. Transplantation 1988; 45: 91.
28. Slomowitz LA, Wilkinson A, Hawkins R, Danovitch G. Evaluation of kidney function in renal transplant patients receiving long-term cyclosporine. Am J Kidney Dis 1990; 15: 530.
29. Burke JF, Pirsch JD, Ramos EL, et al. Long-term efficacy and safety of cyclosporine in renal-transplant recipients.N Engl J Med 1994; 331: 358.
30. Lorber MI, Flechner SM, Van Buren CT, Kerman RH, Kahan BD. Cyclosporine, azathioprine and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients. Transplant Proc 1985; 17 (suppl 1): 282.
31. Rocher LL, Hodgson RJ, Merion RM, et al. Amelioration of chronic renal allograft dysfunction in cyclosporine-treated patients by addition of azathioprine. Tranplantation 1989; 47: 249.
32. Pascual J, Marcen R, Orofino L, et al. Evidence that addition of azathioprine improves renal function in clyclosporine-treated patients with allograft dysfunction. Transplantation 1991; 52: 276.
33. Kasiske BL, Heim-Duthoy K, Ma JZ. Elective cyclosporine withdrawal after renal transplantation: a meta-analysis. JAMA 1993; 269: 395.
34. Almond PS, Matas A, Gillingham K, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993; 55: 752.
35. First MR. Renal transplantation for the nephrologist: new immunosuppressive drugs. Am J Kidney Dis 1992; 19: 3.
36. Myers BD. Cyclosporine nephrotoxicity. Kidney Int 1986; 30: 964.
37. Myers BD, Sibley R, Newton L, et al. The long-term course of cyclosporine-associated chronic nephropathy. Kidney Int 1988; 33: 590.